XR body illusion for managing pain in fibromyalgia: examining optimal duration, 2025, Todd et al

voner

Senior Member (Voting Rights)
XR body illusion for managing pain in fibromyalgia: examining optimal duration

Todd, Jennifer; Woolford, Kirk; Cheng, Lee; Lee, Michael C.; de Villiers, Elsje; Finn, Deanna; Aspell, Jane E.

Abstract
Abstract: Background Fibromyalgia is a chronic condition characterised by widespread pain, as well as sleep disturbances, fatigue, and memory and concentration difficulties. Research suggests that an alteration in how the brain represents multisensory inputs from the body may cause or maintain chronic pain conditions, including fibromyalgia. Extended reality (XR) and virtual reality setups generating multisensory conflicts have been shown to alleviate pain, however, the optimal duration for such interventions remains unexplored. Here, we aimed to determine an optimal duration for the cardio-visual full body illusion (FBI) in fibromyalgia, considering both tolerability and changes in pain.

Methods: Participants wore headsets to view a video of their own body, filmed from behind, and their virtual body flashed in synchrony with their heartbeat. We used an established dose-finding protocol to determine the ideal duration (balancing benefit and tolerability). Seven cohorts of participants ( N = 20) were exposed to different durations of the FBI, with adjustments to duration made according to predefined criteria. Measures included a numeric rating scale for pain intensity, pressure pain thresholds, and scales measuring fibromyalgia symptom severity and impact.

Results: We found a quadratic relationship between session duration and changes in self-reported pain-intensity, with 8–16-min durations yielding the most significant improvements. Notably, in the 12-min cohorts pain relief was sustained at 24-h follow-up, and this is the recommended duration for future research.

Conclusions: These findings represent a key step towards developing an effective non-pharmacological intervention for fibromyalgia. Future dose-optimisation research should explore the optimum number of sessions and spacing between sessions.

full text: https://link.springer.com/content/pdf/10.1007/s10055-025-01241-x.pdf

Web | DOI | PMC | PDF | Virtual Reality
 
The changes appears to be quite small, the sample sizes are very small, and they didn’t find a dose response relationship for the only quasi-objective measurement, the pressure pain threshold.
 
How much more evidence is needed to make the case that this entire way of assessing potential treatments is so flawed as to be useless? The whole thing needs to be reformed, every single thing. It doesn't matter that it uses modern technology and relies on computers to run statistical analyses, this is the old way, pre-science, and it's just as worthless today as it ever was.

What a complete waste.
 
Back
Top Bottom